Therapy-Related Myelodysplastic Syndrome

14 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Therapy-Related Myelodysplastic Syndrome

Record	Firm	Date
Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome (NCT05379166)	Uma Borate	2022-06-23
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies (NCT05316701)	Orca Biosystems, Inc.	2022-06-21
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies (NCT03272633)	Rutgers, The State University of New Jersey	2020-10-26
Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT04550442)	M.D. Anderson Cancer Center	2020-09-04
Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome (NCT04160052)	M.D. Anderson Cancer Center	2019-10-01
Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome (NCT03359460)	University of California, Davis	2017-12-01
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma (NCT03096782)	M.D. Anderson Cancer Center	2017-10-13
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT02960646)	M.D. Anderson Cancer Center	2017-01-18
Personalized NK Cell Therapy in CBT (NCT02727803)	M.D. Anderson Cancer Center	2016-05-19
Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia (NCT02658487)	Vanderbilt-Ingram Cancer Center	2016-03-01
Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia (NCT01885689)	City of Hope Medical Center	2014-02-10
Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies (NCT01823198)	M.D. Anderson Cancer Center	2013-06-11
NK Cells in Cord Blood Transplantation (NCT01619761)	M.D. Anderson Cancer Center	2013-05-03

Track Therapy-Related Myelodysplastic Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.